Flucloxacillin in the treatment of atopic dermatitis

C I Ewing1, C Ashcroft, A C Gibbs

  • 1Department of Child Health, University of Manchester, U.K.

Insights

Antibiotic treatment for atopic dermatitis in children did not improve symptoms, despite temporarily reducing Staphylococcus aureus colonization. Further research is needed for effective eczema management.

Area of Science:

  • Dermatology
  • Microbiology
  • Pediatrics

Background:

  • Atopic dermatitis (eczema) frequently involves Staphylococcus aureus colonization.
  • Bacterial infections are common in eczema patients.
  • The efficacy of antibiotics in children with eczema but no overt bacterial infection is unclear.

Purpose of the Study:

  • To investigate the effect of oral flucloxacillin on Staphylococcus aureus colonization and clinical symptoms in children with atopic dermatitis.
  • To determine if antibiotic therapy benefits children with eczema lacking signs of bacterial infection.

Main Methods:

  • A randomized, double-blind, placebo-controlled study involving 50 children aged 1-16 years with atopic dermatitis.
  • Four weeks of oral flucloxacillin treatment followed by an 8-week follow-up period.
  • Skin colonization of S. aureus was quantified before, during, and after treatment.

Main Results:

  • Flucloxacillin significantly reduced S. aureus counts after 4 weeks compared to placebo (P = 0.008).
  • This reduction was temporary, with no significant difference in S. aureus counts 14 days after treatment cessation (P = 0.32).
  • No improvement in atopic dermatitis symptoms or clinical appearance was observed. Methicillin-resistant S. aureus was identified in five children.

Conclusions:

  • Oral flucloxacillin temporarily reduces S. aureus skin colonization in children with atopic dermatitis.
  • Antibiotic therapy does not improve clinical symptoms of atopic dermatitis in children without evident bacterial infection.
  • The findings suggest limited benefit of routine antibiotic use for uncomplicated atopic dermatitis.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...